1Rockall TA, Logan RF, Devlin HB, et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut, 1996, 38:316-321.
2British Society of Gastroenterology Endoscopy Committee. Nonvariceal upper gastrointestinal haemorrhage : guidelines. Gut, 2002,51 Suppl 4:iv1-6.
3Barkun A, Bardou M, Marshall JK. Nonvariceal Upper GI Bleeding Consensus Conference Group. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding.Ann Intern Med, 2003, 139:843-857.
4Simoens M, Rutgeerts P. Non-variceal upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol, 2001.15 : 121-133.
5Das A, Wong RC. Prediction of outcome of acute GI hemorrhage : a review of risk scores and predictive models. Gastrointest Endosc,2004, 60:85-93.
6Gralnek IM, Dulai GS. Incremental value of upper endoscopy for triage of patients with acute non-variceal upper-GI hemorrhage.Gastrointest Endosc, 2004, 60:9-14.
7Marmo R, Rotondano G, Bianco MA. Outcome of endoscopic treatment for peptic ulcer bleeding: is a second look necessary? A meta-analysis. Gastrointest Endosc, 2003,57:62-67.
8Barkun AN, Herba K, Adam V, et al. High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis. Aliment Pharmacol Ther,2004,19:591-600.
9Erstad BL. Cost-effectiveness of proton pump inhibitor therapy for acute peptic ulcer-related bleeding. Crit Care Med, 2004, 32:1277-1283.
10Imperiale TF, Birgisson S. Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage : a meta-analysis. Ann Intern Med,1997, 127 : 1062-1071.
